Catalyst Health (CHSI) Boosts FY11 EPS, Sales Outlook
Tweet
Share
E-mailGet Alerts CHSI Hot Sheet
Join SI Premium – FREE
Catalyst Health (Nasdaq: CHSI) raises its FY11 adj-EPS guidance from $2.20-$2.39 to $2.30-$2.40, which compares to the Street estimate of $2.29. Sees sales of $5.1-$5.3 billion, versus the consensus of $5.2 billion. The company previously guided FY sales to $4.6-$4.8 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
- Marti Technologies (MRT) Misses Q2 EPS by 9c ; Offers Guidance
Create E-mail Alert Related Categories
Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
